Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

about

Amyloid β42 peptide is toxic to non-neural cells in Drosophila yielding a characteristic metabolite profile and the effect can be suppressed by PI3K.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.

P2860

Q47151964-CFA95E6B-8716-423B-B083-ED77683CB8CB Q55383590-2D6716CD-D737-4666-86F4-368753EA57E4

P2860

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

Item

http://www.wikidata.org/entity/Q39098473

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@en

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@nl

type

Item

label

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@en

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@nl

prefLabel

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@en

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@nl

P1476

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

@en

P2093

Charisse Somers

http://www.w3.org/2001/XMLSchema#string

Joery Goossens

http://www.w3.org/2001/XMLSchema#string

Maria Bjerke

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

The amyloid hypothesis of Alzheimer's disease at 25 years

Neuropathological stageing of Alzheimer-related changes

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

P304

169-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM-2016-0276

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sebastiaan Engelborghs

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28111962

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

biomarker

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

about

P2860

P2860

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921